Clinical Trials Browser

Phase 2 × Skin Neoplasms × Vemurafenib × Clear all

NCT01474551 2015-11-18

Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation

Phase 2 Terminated

2 enrolled 6 charts

Melanoma, Skin Neoplasms